- Rockley Photonics Holdings Ltd RKLY expanded the range of possible applications for its non-invasive biomarker sensing technology into new segments of the medical technology field.
- Rockley collaborated with two leading medical equipment and device manufacturers, who have a combined history of over 200 years and represent over $40 billion of revenue in the medical equipment market.
- Cowen analyst Paul Silverstein initiated coverage of the silicon photonics technology company with an Outperform rating and $22 price target, implying an upside of 134.5%.
- Price Action: RKLY shares traded higher by 6.99% at $10.05 in the market session on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
